Teriparatide [Human PTH(1-34)]: 2.5 Years of Experience on the Use and Safety of the Drug for the Treatment of Osteoporosis

This publication has 59 references indexed in Scilit:

• Primary Hyperparathyroidism and Osteosarcoma: Examination of a Large Cohort Identifies Three Cases of Fibroblastic Osteosarcoma
  Journal of Bone and Mineral Research, 2005
• Osteoclast-derived activity in the coupling of bone formation to resorption
  Trends in Molecular Medicine, 2005
• The Chloride Channel Inhibitor NS3736 Prevents Bone Resorption in Ovariectomized Rats Without Changing Bone Formation
  Journal of Bone and Mineral Research, 2004
• Bone Neoplasms in F344 Rats Given Teriparatide [rhPTH(1-34)] Are Dependent on Duration of Treatment and Dose
  Toxicologic Pathology, 2004
• Mechanisms of Bone Metastasis
  New England Journal of Medicine, 2004
• Osteoblastic cells regulate the haematopoietic stem cell niche
  Nature, 2003
• Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone
  Journal of Cellular Biochemistry, 2003
• Implant fixation enhanced by intermittent treatment with parathyroid hormone
  The Journal of Bone and Joint Surgery. British volume, 2001
• Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
  Published by Elsevier ,1997
• Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial.
  BMJ, 1980